Gallagher Carol Giltner's Form 4 filing
Atara Biotherapeutics, Inc. (ATRA) · filed Nov 15, 2023
- Accession no.
- 0000905148-23-001457
- Filed
- Nov 15, 2023, 5:07 PM ET
- Trade date
- Nov 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $68.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gallagher Carol GiltnerCIK 0001329959 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +179,020 | $0.2236 | +$40,028.87 | 368,438 | Direct | |
| Nov 14, 2023 | Common Stock | PPurchaseAcquired | +90,980 | $0.3098 | +$28,185.6 | 459,418 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.